Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa

Hisham A Abbas1, Ahmed M Elsherbini2, Moutaz A Shaldam3

  • 1Department of Microbiology and Immunology-Faculty of Pharmacy-Zagazig University- Zagazig- Egypt.

African Health Sciences
|November 1, 2017
PubMed
Abstract

Insights

Metformin inhibits quorum sensing in Pseudomonas aeruginosa by targeting key receptors. This virulence inhibiting agent reduces bacterial virulence factors and biofilm formation, offering a potential treatment for infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Bacterial Communication

Background:

  • Quorum sensing regulates virulence factors in Pseudomonas aeruginosa.
  • Inhibiting quorum sensing disarms bacteria without promoting antibiotic resistance.

Purpose of the Study:

  • Identify a novel quorum sensing inhibitor.
  • Evaluate inhibitory effects against Pseudomonas aeruginosa PAO1 virulence factors.

Main Methods:

  • Assessed quorum sensing via violacein production in Chromobacterium violaceum.
  • Utilized molecular docking to study metformin binding to LasR and rhlR receptors.
  • Measured inhibition of pyocyanin, hemolysin, protease, elastase, motility, biofilm, and oxidative stress resistance.

Main Results:

  • Metformin significantly reduced violacein production and inhibited key virulence factors (pyocyanin, hemolysin, protease, elastase).
  • Metformin decreased biofilm formation, motility, and increased oxidative stress sensitivity.
  • Molecular docking indicated metformin binds to LasR and rhlR receptors.

Conclusions:

  • Metformin functions as a quorum sensing inhibitor.
  • Metformin exhibits virulence-inhibiting properties against Pseudomonas aeruginosa.
  • Metformin shows potential for treating Pseudomonas aeruginosa infections.